Rare diseases
Investigational molecules
Locations
331 conditions with trials, the busiest first
872 trials across Europe, recruiting first
Study on the Safety and Effects of AMB-05X Injections for Patients with Tenosynovial Giant Cell Tumor
The NetherlandsStudy on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy
GermanyStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
AustriaStudy on Tofacitinib for Patients with Early Active Axial Spondyloarthritis Who Did Not Respond to NSAIDs
BulgariaStudy Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor
BelgiumStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
AustriaStudy on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease
GermanyStudy of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis
BelgiumStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
BelgiumStudy on the Safety and Effectiveness of ABC008 for Patients with Inclusion Body Myositis
BelgiumStudy on Montelukast for Pain Relief in Patients with Erosive Hand Osteoarthritis
SpainGene Therapy Study for Patients with Limb-Girdle Muscular Dystrophy Using GNT0006
DenmarkThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
